Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human DLL3 Anticorps:
anti-Mouse (Murine) DLL3 Anticorps:
anti-Rat (Rattus) DLL3 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal DLL3 Primary Antibody pour EIA, IF - ABIN951923
Heuss, Ndiaye-Lobry, Six, Israël, Logeat: The intracellular region of Notch ligands Dll1 and Dll3 regulates their trafficking and signaling activity. dans Proceedings of the National Academy of Sciences of the United States of America 2008
Show all 3 references for ABIN951923
Human Polyclonal DLL3 Primary Antibody pour EIA, IF - ABIN951924
Yerges, Klei, Cauley, Roeder, Kammerer, Moffett, Ensrud, Nestlerode, Marshall, Hoffman, Lewis, Lang, Barrett-Connor, Ferrell, Orwoll, Zmuda: High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. dans Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009
Show all 3 references for ABIN951924
Human Polyclonal DLL3 Primary Antibody pour IF, IHC (p) - ABIN656327
Maisenbacher, Han, Obrien, Tracy, Erol, Schaffer, Dormans, Zackai, Kusumi: Molecular analysis of congenital scoliosis: a candidate gene approach. dans Human genetics 2005
Show all 3 references for ABIN656327
The Dll3 was rarely detectable in (Montrer PIK3CA Anticorps) the (Montrer AKT1 Anticorps) para-carcinoma tissues, but positi (Montrer NOTCH1 Anticorps)ve in 82.1% of non-small cell cancer tissues.
Both global haplotype and individual haplotype analyses showed that the haplotypes of SNP1/SNP2/SNP3/SNP4/SNP5 did not correlate with the disease (P >0.05). Together, these data suggest that genetic variants of the DLL3 gene are not associated with CS in the Chinese Han population.
DLL3 was silenced by methylation in human human hepatocellular carcinoma and it negatively regulates the growth of human hepatocellular carcinoma cells.
We suggest that the three human DLL3 mutations associated with spondylocostal dysplasia are also functionally equivalent to the Dll3(neo) null allele in mice.
mutations in DLL3 cause a consistent pattern of abnormal vertebral segmentation in spondylocostal dysostosis
no novel or previously described mutations are present in our cohort, indicating that DLL3 mutations may not be a major cause of congenital scoliosis.
The intracellular region of Notch (Montrer NOTCH1 Anticorps) ligands Dll1 (Montrer DLL1 Anticorps) and Dll3 regulates their trafficking and signaling activity
Dll3 overexpression promoted PI3K/Akt (Montrer AKT1 Anticorps) signaling through inhibiting Notch (Montrer NOTCH1 Anticorps) signaling in lung cancer.
O-fucosylation of DLL3 is required for its function during somitogenesis.
Intriguing changes are observed in the cranio-caudal (Montrer CAD Anticorps) borders of multifidus muscle in mutant Dll3 and Lfng (Montrer LFNG Anticorps) models of idiopathic scoliosis.
Dll3 has a unique function during T-cell development that is distinct from the role played by the other DSL ligands of Notch (Montrer NOTCH1 Anticorps).
Dll3 targets Notch1 (Montrer NOTCH1 Anticorps) for lysosomal degradation preventing Notch1 (Montrer NOTCH1 Anticorps) from undergoing post-translational processing.
Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm.
DLL3 knockout mice have segmentation and neural defects
Notch (Montrer NOTCH1 Anticorps) ligands, including Delta-like1 and 3 and Jagged1 (Montrer JAG1 Anticorps) and Jagged2 (Montrer JAG2 Anticorps), show distinct expression patterns in the developing and adult brain overlapping that of Notch1 (Montrer NOTCH1 Anticorps)
Data describe the genetic interactions between Dll1 (Montrer DLL1 Anticorps), Dll3, Mesp2 (Montrer Mesp2 Anticorps) and Psen1 (Montrer PSEN1 Anticorps), and the roles of Dll1 (Montrer DLL1 Anticorps)- and Dll3-Notch (Montrer NOTCH1 Anticorps) pathways, with or without Psen1 (Montrer PSEN1 Anticorps), in rostrocaudal patterning.
spondylocostal dysostosis (SCD (Montrer SCD Anticorps)) is caused by mutation in Delta-like (Montrer DLK1 Anticorps) 3 (DLL3), Mesoderm posterior 2 (MESP2 (Montrer Mesp2 Anticorps)), and Lunatic fringe (LFNG (Montrer LFNG Anticorps)); three genes that are components of the Notch (Montrer NOTCH1 Anticorps) signaling pathway.
This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene.
delta-like protein 3
, drosophila Delta homolog 3